What is the main business of USP Zdrowie?

The main business activity of USP Zdrowie focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 1, 2010.

Where is the headquarters located?

The headquarters is located at: ul. Poleczki 35, 02-822 Warszawa.

Who is on the management board?

The management board includes Marcin Andrzej Szałapski (Vice President of the Management Board).

What is the share capital?

The share capital of the company is PLN 25,610,250 (approx. $6.9 million).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

The company reported a revenue of $353,319,819 in 2024, which is an increase of 9.2% compared to 2023.

Yes, the company recorded a net profit of $25,494,527 in 2024, meaning the company decreased its profit by 31.0%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $151,213,590 in 2024, representing 49% of all operating expenses.

USP Zdrowiesp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2010-02-01

Share capital

25 610 250,00 PLN

Activity description

USP Zdrowie has been a leader in Poland’s over-the-counter (OTC) medicines and healthcare products market for more than 30 years. The company develops 40 health-related brands, including Ibuprom, Apap and Gripex, and employs 600 people.

Registered address

ul. Poleczki 35, 02-822 Warszawa, Poland

Website

uspzdrowie.pl

Phone

Social media

Electronic delivery address

AE:PL-72546-53316-EFBGT-15

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 377.15mMedianUSD 874.80kAverageUSD 20.30m

Net profit

This companyUSD 34.55mMedianUSD 28.22kAverageUSD 816.54k

Operating costs

This companyUSD 325.63mMedianUSD 805.63kAverageUSD 19.09m

Assets

This companyUSD 299.66mMedianUSD 541.73kAverageUSD 10.95m

News

2026-09-30

ISKIAL MAX in a New Edition: "Scandinavian Strength of Immunity"

2026-09-24

Three USP Zdrowie Brand Campaigns Nominated for Effie Awards Poland 2026

2026-07-07

Recall of Verdin Fix Product Batches L:26/062P, L:26/068N and L:26/077P

Industry

Bank accounts

Registered as a VAT taxpayer on 2010-08-17. Active

mBank
53 1140 2062 0000 5324 7300 1053
mBank
80 1140 2062 0000 5324 7300 1052
Erste Bank Polska
61 1090 1056 0000 0001 6754 1421

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

Type	Amount
Buildings and premises	PLN 437.5KPLN 437,492

MSiG notices

Publication date	Event
Feb 12, 2018	Call to creditors
Mar 27, 2012	Call to creditors
Jan 19, 2011	Merger registered
Sep 9, 2010	Merger registered

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Trademarks

USP Zdrowie holds 32 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 1997.

Mark	Number	Classes	Status	Protected until
USP Zdrowie	Z.501067	3, 5, 10, 35, 39, 40, 41, 42, 44	Protected	Jun 12, 2029
USP Zdrowie	Z.501057	3, 5, 10, 35, 39, 40, 41, 42, 44	Protected	Jun 12, 2029
Centrum Stworzone dla Zdrowia	Z.501056	3, 5, 10, 35, 39, 40, 41, 42, 44	Protected	Jun 12, 2029
USP Zdrowie(word)	Z.474624	3, 5, 10	Protected	Jul 25, 2027
US Pharmacia(word)	Z.474625	3, 5, 10	Protected	Jul 25, 2027

Mark	Protected until
USP Zdrowie	Jun 12, 2029
USP Zdrowie	Jun 12, 2029
Centrum Stworzone dla Zdrowia	Jun 12, 2029
USP Zdrowie(word)	Jul 25, 2027
US Pharmacia(word)	Jul 25, 2027

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Marcin Andrzej Szałapski – Vice President of the Management Board

Anna Czyż – Attorney-in-fact (joint)

Małgorzata Brzozowska Bejgier – Attorney-in-fact (joint)

Robert Jurgawka – President of the Management Board

Krzysztof Nowakowski – Attorney-in-fact (joint)

Manner of representation

Two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy.

Supervisory board

Francis Patrick Ostronic – Supervisory Board Member

Kazimierz Janusz Napiórkowski – Supervisory Board Member

Katarzyna Kuśmierz – Supervisory Board Member

Ownership

Owner	Shares	Share value	Stake
Medvic S.a.r.l.	512,205	$6,917,949.76	100%

Beneficial owners

Person	Rights

Subsidiaries

	Name	Share value	Stake
	Healthilysp. z o.o.	10,995,407.89 USD	100%
	Selfish 3sp. z o.o.	10,116.15 USD	24.9667%

Competitors

Name	Revenue	Website
Bayersp. z o.o.	$624,313,880.67	talent.bayer.com
Essity Polandsp. z o.o.	$563,485,192.26	essity.com
HurtapS.A.	$480,276,955.20	hurtap.com.pl
Bausch Health Polandsp. z o.o.	$433,316,311.35	bauschhealthpoland.pl
Komtur Polskasp. z o.o.	$424,362,396.43	komtur.pl
Sanofisp. z o.o.	$384,123,246.36	sanofi.com
Novartis Polandsp. z o.o.	$378,147,128.47	novartis.com
MSD Polska Dystrybucjasp. z o.o.	$341,786,056.16	msd.pl
Pfizer Trading Polskasp. z o.o.	$299,067,553.99	pfizer.pl
Bialmedsp. z o.o.	$203,238,055.12	bialmed.pl

Change history

Date	Event
2025-03-11	Address change (Poleczki/35, 02-822, Warszawa → Ul. Poleczki 35, 02-822, Warszawa)
2018-05-29	Share capital change (63,299,550.00 PLN → 25,610,250.00 PLN)
2017-01-26	Share capital change (60,114,900.00 PLN → 63,299,550.00 PLN)
2015-05-29	PKD change (Removed: 17.29.Z, 46.18.Z, 46.31.Z, 46.37.Z, 46.90.Z, 47.11.Z, 47.19.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.78.Z, 47.99.Z, 49.41.Z, 58.12.Z, 58.19.Z, 63.12.Z, 63.99.Z, 70.21.Z, 71.20.A, 71.20.B, 72.19.Z, 73.11.Z, 73.12.A, 73.12.B, 73.12.C, 73.12.D, 74.90.Z, 77.40.Z, 78.10.Z, 78.30.Z, 82.91.Z, 82.92.Z, 82.99.Z, 85.51.Z, 85.60.Z, 96.09.Z)
2012-07-20	Share capital change (260,114,900.00 PLN → 60,114,900.00 PLN)

FAQ

Last updated: 2026-10-07